Trials / Recruiting
RecruitingNCT05896020
A Study of SHR-A1811 in Subjects With Gynaecologic Oncology
Open, Multicenter Phase II Clinical Study of SHR-A1811 for Injection in the Treatment of Gynaecological Malignancies
- Status
- Recruiting
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 225 (estimated)
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd. · Industry
- Sex
- Female
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
This is an open-label, two-part study to evaluate the safety and efficacy of SHR-A1811 for injection in subjects with a gynaecological malignancies.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | SHR- A1811 | Subjects with gynaecological malignancies |
Timeline
- Start date
- 2023-07-10
- Primary completion
- 2026-06-15
- Completion
- 2026-06-15
- First posted
- 2023-06-09
- Last updated
- 2023-08-22
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05896020. Inclusion in this directory is not an endorsement.